Health Press Release – Newsletter for March 3, 2011

WISeKey Appoints Dr. Adrienne Corboud Fumagalli, EPFL Vice President for Innovation and Technology Transfer, to its Advisory Committee

GENEVA, March 2, 2011 – WISeKey announced the appointment of Dr. Adrienne Corboud
Fumagalli as a member of its Advisory Committee. The committee, chaired by
Carlos Moreira, WISeKey founder and CEO, provides advice to WISeKey's senior
management regarding matters of strategic business development and future
revenue growth.

Dr. Adrienne Corboud Fumagalli holds the position of …. Original article  : WISeKey Appoints Dr. Adrienne Corboud Fumagalli, EPFL Vice President for Innovation and Technology Transfer, to its Advisory Committee.

Naviscan Announces European Launch of Positron Emission Mammography

European Launch Marked By Presentations of Significant New Clinical Data Demonstrating the Value of PEM in Improving Treatment Decisions for Breast Cancer

VIENNA, March 2, 2011 – Naviscan, Inc., announces the European launch of the Naviscan Positron
Emission Mammography (PEM) scanner at two prestigious radiology conferences
in Vienna. On March 3rd, at the European Society of Breast …. Source  : Gaea News Network.

InspireMD Boosts MGuard Production Capacity

Production Capacity of MGuard, the Unique Thrombus Management Stent System, Will Double in 2011 to Meet Steady Increase in Demand

TEL AVIV, Israel, March 2, 2011 – InspireMD (www.inspire-md.com/site_en/), developer of
the MGuard(TM) net protective stent system (
www.inspire-md.com/site_en/mguard/the-technology/), has expanded its
MGuard production facilities to meet the steady increase in demand. The
driving forces behind the accelerating demand …. Original source  : InspireMD Boosts MGuard Production Capacity.

Accumetrics Signs Development & Supply Agreement With Portola Pharmaceuticals, Inc.

VerifyNow System to be used in Drug Developer's Clinical Studies
SAN DIEGO, March 2, 2011 – Accumetrics, Inc., a privately-held developer and marketer of the
VerifyNow System, the first rapid and easy-to-use point-of-care diagnostic
system for measuring platelet reactivity to multiple antiplatelet agents,
announced today that the company has signed an agreement with Portola
Pharmaceuticals, Inc. to develop and … Read more »».

Torchmark Corporation Declares Dividend

MCKINNEY, Texas, March 2, 2011 – Torchmark Corporation (NYSE: TMK) announced that its Board of Directors
has declared a quarterly dividend of $.16 per share on all of the outstanding
common stock of the Company held of record as of the close of business of the
Company's transfer agent on April 1, 2011. The dividend will be … Original article on : Torchmark Corporation Declares Dividend.